# Atrial Fibrillation in Cryptogenic Stroke and TIA

> **NCT02937077** · — · COMPLETED · sponsor: **Oslo University Hospital** · enrollment: 259 (actual)

## Conditions studied

- Atrial Fibrillation
- Ischemic Stroke
- TIA

## Interventions

- **DEVICE:** Medtronic Reveal LINQ

## Key facts

- **NCT ID:** NCT02937077
- **Lead sponsor:** Oslo University Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-12
- **Primary completion:** 2021-10
- **Final completion:** 2021-10
- **Target enrollment:** 259 (ACTUAL)
- **Last updated:** 2022-01-25

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02937077

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02937077, "Atrial Fibrillation in Cryptogenic Stroke and TIA". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02937077. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*